| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $9.44M | $10.91M | $10.02M | $10.16M | $10.65M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $28.25M | $38.56M | $39.50M | $43.28M | $34.88M |
| SG&A | $14.05M | $16.79M | $18.65M | $19.65M | $17.30M |
| Operating Income | -$5.71M | -$44.54M | -$48.33M | -$53.02M | -$42.06M |
| Interest Expense | – | – | – | – | $0.00 |
| Tax Expense | $0.00 | $0.00 | – | – | – |
| Net Income | -$7.58M | -$43.39M | -$47.41M | -$56.67M | -$45.44M |
| EPS (basic) | -0.5800 | -6.8800 | -8.9600 | 0.6100 | -0.5000 |
| EPS (diluted) | -0.5800 | -6.8800 | -8.9600 | 0.6100 | -0.5000 |
| Shares (diluted) | $13.16M | $6.31M | $5.29M | $93.39M | $91.57M |